Erratum to"A proper schedule of weekly paclitaxel and gemcitabine combination is highly active and very well tolerated in NSCLC patients" [Lung cancer 54 (2006) 359-364] (DOI: 10.1016/j.lungcan.2006.08.016)

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)431
Number of pages1
JournalLung Cancer
Issue number3
Publication statusPublished - Dec 2007

ASJC Scopus subject areas

  • Oncology

Cite this